These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 20815808)
1. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Gui J; Tian Y; Wen X; Zhang W; Zhang P; Gao J; Run W; Tian L; Jia X; Gao Y Clin Sci (Lond); 2011 Mar; 120(5):183-93. PubMed ID: 20815808 [TBL] [Abstract][Full Text] [Related]
2. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
3. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma. Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637 [TBL] [Abstract][Full Text] [Related]
4. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493 [TBL] [Abstract][Full Text] [Related]
7. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953 [TBL] [Abstract][Full Text] [Related]
8. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma. Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235 [TBL] [Abstract][Full Text] [Related]
9. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein. Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313 [TBL] [Abstract][Full Text] [Related]
10. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Chen Y; Chen J; Liu Y; Li S; Huang P Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771 [TBL] [Abstract][Full Text] [Related]
11. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage. Lin L; Lu B; Yu J; Liu W; Zhou A Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963 [TBL] [Abstract][Full Text] [Related]
12. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [TBL] [Abstract][Full Text] [Related]
13. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients. Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580 [TBL] [Abstract][Full Text] [Related]
14. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
15. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients. Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876 [TBL] [Abstract][Full Text] [Related]
16. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
17. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Jiang L; Cheng Q; Zhang BH; Zhang MZ Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179 [TBL] [Abstract][Full Text] [Related]
20. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]